You just read:

Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic Breast Cancer

News provided by

Oncolytics Biotech Inc.

Dec 05, 2017, 06:00 ET